Medicare Enrolled

Dr. Steven Fein, M.D.

Hematology & Oncology · Miami, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
8255 S DIXIE HWY, Miami, FL 33143
3054581384
In practice since 2005 (20 years)
NPI: 1437146552 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fein

Dr. Steven Fein is a hematology & oncology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Fein performed 51,868 Medicare services across 845 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fein received a total of $1,190,321 from 54 pharmaceutical and/or device companies across 1441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 16% volume in FL$ $1,190,321 industry payments

Medicare Practice Summary

Medicare Utilization ↗
51,868
Medicare services
Top 16% in FL for hematology & oncology
845
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,593 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)50,490$0$20
Hospital follow-up visit, high complexity353$98$875
Office visit, established patient (30-39 min)275$89$1,030
Initial hospital admission, high complexity176$139$1,687
New patient office visit (45-59 min)121$109$1,581
Hospital follow-up visit, moderate complexity115$59$315
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less109$54$690
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour107$17$207
Office visit, established patient (20-29 min)90$49$701
Office visit, established patient, complex (40-54 min)32$101$207
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
97.8% high complexity
0.0% medium
2.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,190,321
Total received (2018-2024)
Avg $170,046/year across 7 years
Top 1% in FL for hematology & oncology
54
Companies
1,441
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,104,644 (92.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$62,385 (5.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,292 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$90,607
2023
$93,599
2022
$169,479
2021
$288,140
2020
$147,586
2019
$156,157
2018
$244,752

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$194,865
Pharmacosmos Therapeutics Inc.
$142,261
Daiichi Sankyo Inc.
$131,547
PFIZER INC.
$108,300
Dova Pharmaceuticals
$106,727
Incyte Corporation
$82,510
Sobi, Inc
$61,824
Agios Pharmaceuticals, Inc.
$59,627
GENZYME CORPORATION
$49,920
Novartis Pharmaceuticals Corporation
$38,616
Janssen Pharmaceuticals, Inc
$38,405
BeiGene USA, Inc.
$27,506
SOBI, INC
$24,424
Celgene Corporation
$21,421
BTG International, Inc.
$16,859
Bayer HealthCare Pharmaceuticals Inc.
$15,272
Rigel Pharmaceuticals, Inc.
$7,828
Seattle Genetics, Inc.
$7,607
Pharmacyclics LLC, An AbbVie Company
$7,241
BTG INTERNATIONAL, INC.
$6,300
E.R. Squibb & Sons, L.L.C.
$6,026
PORTOLA PHARMACEUTICALS, INC.
$5,653
Kite Pharma, Inc.
$5,491
NOVARTIS PHARMACEUTICALS CORPORATION
$4,128
Gilead Sciences, Inc.
$3,598
Octapharma USA, Inc.
$3,121
Takeda Pharmaceuticals U.S.A., Inc.
$2,823
Teva Pharmaceuticals USA, Inc.
$2,330
BIOVERATIV THERAPEUTICS INC.
$2,012
Janssen Research & Development, LLC
$1,502
Epizyme, Inc.,
$1,330
Servier Pharmaceuticals LLC
$775
SERVIER PHARMACEUTICALS LLC
$674
Janssen Scientific Affairs, LLC
$230
Astellas Pharma US Inc
$176
SANOFI-AVENTIS U.S. LLC
$157
AstraZeneca Pharmaceuticals LP
$140
Alexion Pharmaceuticals, Inc.
$127
Merck Sharp & Dohme Corporation
$124
Ipsen Biopharmaceuticals, Inc
$121
Genentech USA, Inc.
$120
Stemline Therapeutics Inc.
$118
EMD Serono, Inc.
$81
Bayer Healthcare Pharmaceuticals Inc.
$79
Terumo BCT, Inc.
$63
Merck Sharp & Dohme LLC
$56
American Regent
$50
RefleXion Medical, Inc.
$43
Janssen Biotech, Inc.
$29
RECORDATI_RARE_DISEASES_INC.
$21
G1 Therapeutics, Inc.
$19
Seagen Inc.
$18
AbbVie Inc.
$15
Taiho Oncology, Inc.
$13
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ANDEXXA · ASPARLAS · ATTP DISEASE · Aliqopa · BAVENCIO · BESPONSA · BEVYXXA · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CHANTIX · COLD AGGLUTININ DISEASE · COSELA · DARZALEX · DISEASE STATE · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · ENJAYMO · ERLEADA · GAZYVA · IMBRUVICA · IMFINZI · INJECTAFER · INREBIC · Imbruvica · Inrebic · JAKAFI · JEVTANA · KEYTRUDA · Kadcyla · Kyprolis · LONSURF · MONOFERRIC · MYLOTARG · Mirena · Monoferric · NINLARO · NUWIQ · Neulasta · Nplate · ONCASPAR · OPDIVO · Onivyde · PADCEV · PROMACTA · PYRUKYND · Perjeta · REFLEXION MEDICAL RADIOTHERAPY SYSTEM · RYDAPT · Revlimid · SARCLISA · SOLIRIS · SPRYCEL · SYLVANT · Stivarga · TASIGNA · TAZVERIK · Tavalisse · Tibsovo · Truxima · VENCLEXTA · VORAXAZE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XARELTO · XOSPATA · Xofigo · Yescarta · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in FL.

Equivalent to $2,295 per 100 Medicare services performed
Looking for a hematology & oncology in Miami?
Compare hematology & oncologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
154
Per 100K population
5.7
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fein is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fein experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Fein performed 50,490 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fein receive payments from pharmaceutical companies?
Yes. Dr. Fein received a total of $1,190,321 from 54 companies across 1,441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fein's costs compare to other hematology & oncologys in Miami?
Dr. Fein's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →